Cooperative Agreement NU58DP007977
- The National Cancer Institute (NCI), through the Cancer Cause and Prevention Research Program (CFDA 93.393), awarded a $2,124,826 Project Grant to President and Fellows of Harvard College (Harvard T.H. Chan School of Public Health) to optimize a mobile messaging intervention for increasing colorectal cancer (CRC) screening rates among patients at community health centers. The project aims to use a two-phase process to first determine optimal messaging strategies for maximizing patient engagement...
- The National Cancer Institute (NCI) awarded a $697,198 Project Grant under the Cancer Detection and Diagnosis Research program (CFDA 93.394) to the University of California, San Diego (UC San Diego Health) for the project "Optimal Early Colorectal Cancer Screening Initiation" from January 1, 2025 to December 31, 2027. The grant supports research to develop a targeted colorectal cancer screening strategy for adults aged 45-49, with the goal of maximizing screening uptake and...
- This Project Grant award, provided by the National Cancer Institute (NCI) under the Cancer Cause and Prevention Research program (CFDA 93.393), will fund a study to evaluate the impact of social determinants of health (SDOH) on early-onset colorectal cancer (EOCRC) diagnosis, treatment delays, and survival, with a focus on underserved populations in Kentucky and Georgia. The $192,610 award will support a 2-year epidemiologic study that aims to elucidate the relationship between SDOH measures and...
- This federal Project Grant award of $1,372,725.00 from the National Institute on Minority Health and Health Disparities (CFDA 93.307 - Minority Health and Health Disparities Research) aims to evaluate the use of SMS text-based patient navigation to improve colorectal cancer screening rates among homeless individuals in New York City. The project, conducted by George Washington University, seeks to address the significant disparities in colorectal cancer screening among the 3.5 million people...
- The National Cancer Institute (NCI) awarded a $753,446 Project Grant under the Cancer Cause and Prevention Research (CFDA 93.393) program to Boston Medical Center Corporation (BMC) to develop and evaluate an intervention to improve cervical cancer screening and follow-up in underserved populations. The intervention, known as DOSE-CC, combines education and quality improvement methods to help clinicians enhance their cervical cancer prevention practices. The goal is to adapt BMC's prior...
- The National Cancer Institute (NCI) awarded a $637,596 Project Grant under the Cancer Cause and Prevention Research (CFDA 93.393) program to test a video-based intervention designed to reduce defensive colorectal cancer information avoidance and increase colorectal cancer screening rates. The 5-year project will conduct a randomized controlled trial to confirm the intervention's mechanisms of increasing self-efficacy and positive affect, and evaluate its efficacy in reaching those who tend to...
- This Project Grant award from the National Cancer Institute (CFDA 93.393 Cancer Cause and Prevention Research) provides $547,047 to Georgetown University to conduct a clinical trial testing the bundling of multicancer screening and genetic services navigation to improve cancer health equity among Black and Hispanic women. The project aims to address patient- and organization-level barriers that limit cancer screening and genetic testing rates in these populations, which experience...
- The Health Resources and Services Administration (HRSA) awarded a $499,973 Project Grant under the Health Center Program (CFDA 93.224) to Midtown Community Health Center, Inc. (MCHC) to accelerate colorectal cancer screening among underserved patients in Utah. MCHC is partnering with eight other HRSA health centers, the Huntsman Cancer Institute, and the Association for Utah Community Health to improve screening rates, referral to care, and treatment for patients aged 50-75. The project aims...
- This $625,452 federal Project Grant awarded by the National Institute on Aging (CFDA 93.866 - Aging Research) aims to develop and evaluate a life expectancy-informed clinical decision support intervention to guide colorectal cancer screening decisions in older adults. The project, led by the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, involves a collaboration with The Johns Hopkins University as a sub-awardee. The co-investigator from Johns Hopkins, Dr....
- This Project Grant award from the National Cancer Institute (CFDA 93.393 - Cancer Cause and Prevention Research) provides $442,750.00 to New York University (NYU) to conduct a study on implementation strategies for cervical cancer control policies in Africa. The project aims to: (A) Engage a network of experts from African low- and middle-income countries (LMICs) and global agencies through a Delphi process to identify determinants of policy implementation success, using the Consolidated...
CHANGING HEALTH SYSTEMS USING EVIDENCE-BASED INTERVENTIONS TO INCREASE COLORECTAL CANCER SCREENING - THE NEW YORK STATE DEPARTMENT OF HEALTH (DEPARTMENT) WILL INCREASE COLORECTAL CANCER (CRC) SCREENING RATES ACROSS NEW YORK STATE (NYS) BY PARTNERING WITH PRIMARY CARE CLINICS (FEDERALLY QUALIFIED HEALTH CENTERS (FQHCS) AND RURAL HEALTH CENTERS) WITH CRC SCREENING RATES BELOW 60%, IN REGIONS OF THE STATE OBSERVED TO HAVE DISPARITIES IN CRC SCREENING AND/OR OUTCOMES (INCIDENCE, MORTALITY, DISEASE STAGING) TO INCREASE IMPLEMENTATION AND ENHANCEMENT OF COMMUNITY GUIDE-RECOMMENDED PRIORITY EVIDENCE-BASED INTERVENTIONS (EBIS) (PROVIDER ASSESSMENT AND FEEDBACK, PROVIDER REMINDERS, CLIENT REMINDERS, REDUCING STRUCTURAL BARRIERS AND PATIENT NAVIGATION). THIS WORK WILL RESULT IN SHORT-TERM OUTCOMES THAT SUPPORT PATIENT COMPLETION OF THE CRC SCREENING CONTINUUM, INCLUDING INCREASED STOOL TEST KITS RETURNED AND COLONOSCOPY PROCEDURES COMPLETED, INCREASED CRC SCREENING IN PARTNER CLINICS, AND IDENTIFICATION OF SUPPORT FOR TREATMENT WHEN NEEDED. COLORECTAL CANCER IS THE SECOND LEADING CAUSE OF CANCER DEATH AMONG MEN AND WOMEN IN NYS. OVER 9,000 NEW YORKERS ARE DIAGNOSED WITH CRC ANNUALLY AND APPROXIMATELY 3,000 RESIDENTS DIE EACH YEAR (NYS CANCER REGISTRY). FROM 2017-2021, NEARLY 25% OF CRC CASES IN NYS WERE DIAGNOSED AT A DISTANT STAGE. THE PERCENTAGE OF NYS ADULTS AGED 45 TO 75 YEARS SCREENED FOR CRC WAS 69% IN 2022, THOUGH RATES ARE LOWER IN YOUNGER INDIVIDUALS (33% OF 45-49-YEAR-OLDS), THOSE WITH LOW HOUSEHOLD INCOMES (58% OF THOSE MAKING LESS THAN $25,000), AND THOSE REPORTING NO REGULAR HEALTH CARE PROVIDER (39.7%) (NYS BEHAVIORAL RISK FACTOR SURVEILLANCE SYSTEM). NYS FEDERALLY QUALIFIED HEALTH CENTERS AND RURAL HEALTH CENTERS SERVE THE DEPARTMENT'S TARGET POPULATION FOR THIS PROJECT INCLUDING THOSE LEAST LIKELY TO BE UP TO DATE WITH CRC SCREENING; FOR EXAMPLE, 57 OF NYS' 63 FQHCS REPORT CRC SCREENING RATES BELOW 60%, 48 FQHCS ARE BELOW 50%. BEGINNING IN YEAR 1, THE DEPARTMENT WILL PARTNER WITH FOUR FQHC CLINIC TEAMS AND THEIR CLINIC CHAMPION TO CONDUCT A READINESS ASSESSMENT OF EACH CLINIC'S CAPACITY TO IMPLEMENT EBIS AND THEN COLLABORATIVELY WORK WITH EACH CLINIC TO DEVELOP A QUALITY IMPROVEMENT PLAN TO BE IMPLEMENTED OVER TWELVE MONTHS. THE HEALTH CENTER NETWORK OF NEW YORK (HEALTHEFFICIENT), WHICH HAS EXTENSIVE EXPERIENCE WORKING WITH HEALTH CENTERS TO MAKE EFFECTIVE USE OF THEIR HEALTH INFORMATION TECHNOLOGY, WILL PARTNER WITH THE DEPARTMENT TO SUPPORT CLINICS IN THIS WORK. OTHER SUPPORTING PARTNERS WILL COLLABORATE AS PART OF THE PROJECT TEAM TO ASSIST WITH SCREENING NEEDS AND SHARING RESULTS ACROSS NYS. THE DEPARTMENT WILL CONDUCT MONITORING AND EVALUATION TO ENSURE DATA QUALITY AND WILL SHARE RESULTS ACROSS NYS TO INFORM SPREAD OF BEST PRACTICES AND LESSONS LEARNED. A FORMAL REQUEST FOR APPLICATIONS WILL BE ISSUED TO RECRUIT ADDITIONAL FQHCS AND RURAL HEALTH CENTERS IN FUTURE FUNDING PERIODS. PROJECT ACTIVITIES WILL SUPPORT THE ACHIEVEMENT OF THE INTERMEDIATE OUTCOMES OF INCREASED NUMBERS OF CANCERS PREVENTED, INCREASED DIAGNOSIS OF EARLY-STAGE CRC, AND LONG-TERM OUTCOME OF DECREASING CRC INCIDENCE AND MORTALITY.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $0 | 9/5/25 |